Abstract
Hydrazones are a versatile linker of connecting various classes of organic compounds with a unique structural feature of hydrogen bonding donor and the hydrogen bonding acceptor region. An extensive number of research has been carried out on hydrazone derivatives as a potent class of antitubercular agents. The present review focuses on the chemistry, antitubercular activity and structure activity relationship (SAR) of diverse classes of phenyl and heterocyclic based hydrazones.
Keywords: Alamar blue assay, nucleophilic addition, tuberculosis.
Graphical Abstract
Infectious Disorders - Drug Targets
Title:Hydrazones as a Privileged Structural Linker in Antitubercular Agents: A Review
Volume: 15 Issue: 2
Author(s): Bijo Mathew, Jerad Suresh, Mohamed J. Ahsan, Githa E. Mathew, Dhasthakeer Usman, Puthucode N.S. Subramanyan, Kallivalappil F. Safna and Srinubabu Maddela
Affiliation:
Keywords: Alamar blue assay, nucleophilic addition, tuberculosis.
Abstract: Hydrazones are a versatile linker of connecting various classes of organic compounds with a unique structural feature of hydrogen bonding donor and the hydrogen bonding acceptor region. An extensive number of research has been carried out on hydrazone derivatives as a potent class of antitubercular agents. The present review focuses on the chemistry, antitubercular activity and structure activity relationship (SAR) of diverse classes of phenyl and heterocyclic based hydrazones.
Export Options
About this article
Cite this article as:
Mathew Bijo, Suresh Jerad, Ahsan J. Mohamed, Mathew E. Githa, Usman Dhasthakeer, Subramanyan N.S. Puthucode, Safna F. Kallivalappil and Maddela Srinubabu, Hydrazones as a Privileged Structural Linker in Antitubercular Agents: A Review, Infectious Disorders - Drug Targets 2015; 15 (2) . https://dx.doi.org/10.2174/1871526515666150724104411
DOI https://dx.doi.org/10.2174/1871526515666150724104411 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tuberculosis - Present Medication and Therapeutic Prospects
Current Medicinal Chemistry Targeting Toll-like Receptors in Autoimmunity
Current Drug Targets Update on the Principles and Novel Local and Systemic Therapies for the Treatment of Non-Infectious Uveitis
Inflammation & Allergy - Drug Targets (Discontinued) Fast Microwave Assisted Synthesis of Pyranopyrazole Derivatives as New Anticancer Agents
Current Microwave Chemistry Type II NADH:Menaquinone Oxidoreductase of Mycobacterium tuberculosis
Infectious Disorders - Drug Targets Recent Advances in the Treatment of Helicobacter pylori Infection
Recent Patents on Anti-Infective Drug Discovery Sarcoidosis and Sarcoid Reactions in Endometrial Cancer Cases Masquerading Advanced Stage Malignancy
Current Women`s Health Reviews MICA Molecules in Disease and Transplantation, a Double-Edged Sword?
Current Immunology Reviews (Discontinued) Adherence to Highly Active Antiretroviral Therapy in HIV-Infected Inmates
Current HIV Research New Antifolate Inhibitors for Mycobacterium avium
Medicinal Chemistry Amyloidosis and Auto-Inflammatory Syndromes
Current Drug Targets - Inflammation & Allergy AIDS-Defining Illnesses: A Comparison Between Before and After Commencement of Highly Active Antiretroviral Therapy (HAART)
Current HIV Research The Type III Secretion System as a Source of Novel Antibacterial Drug Targets
Current Drug Targets Anti-Tuberculosis
Current Bioactive Compounds Electrotransfer into Skeletal Muscle for Protein Expression
Current Gene Therapy Cationic Antimicrobial Peptides for Tuberculosis: A Mini-Review
Current Protein & Peptide Science Bioluminescent Quantitation and Detection of Gene Expression During Infectious Disease
Combinatorial Chemistry & High Throughput Screening Th2 Cytokines in Susceptibility to Tuberculosis
Current Molecular Medicine Natural Product-Derived Small Molecule Activators of Hypoxia-Inducible Factor-1 (HIF-1)
Current Pharmaceutical Design New Frontiers in the Therapy of Tuberculosis: Fighting with the Global Menace
Mini-Reviews in Medicinal Chemistry